TSE:9218 stock news
This page provides real-time market news, earnings updates, and company announcements related to Mental Health Technologies Co. Ltd. (TSE:9218).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-02-26 10:10 JST
Jefferies Assigns 65-75% Probability of Best-in-Class Efficacy for Definium Therapeutics, Inc.'s (DFTX) DT120 in Phase III
Finviz2026-02-19 02:33:45
Evercore Notes AbbVie Inc.'s (ABBV) Tremfya Gains Market Share, But Future Earnings Growth May Be Limited
Finviz2026-02-19 02:36:45
Needham Bullish on Neurocrine Biosciences, Inc. (NBIX) Pipeline Amid 2026 Growth Expectations for Crenessity and Ingrezza
Finviz2026-02-19 02:36:45
AtaiBeckley Appoints Michael Faerm as Chief Financial Officer
Finviz2026-02-19 12:03:41
BioXcel Therapeutics to Host Virtual Roundtable Featuring Leading Medical Experts Addressing Latest Developments in Treatment of Acute Agitation in Alzheimer's Dementia
Finviz2026-02-19 12:03:42
BrainsWay Announces New Minority-Stake Investment in Canadian Provider, BrainStim Health Inc.
Finviz2026-02-19 12:33:04
Talkspace Announces Fourth Quarter and Full Year 2025 Results
Finviz2026-02-19 13:03:12
20/20 BioLabs Debuts Trading on Nasdaq Under Ticker Symbol "AIDX" Following 3 Consecutive Years of Sales Growth
Finviz2026-02-19 14:03:33
FDA could approve magic mushroom chemical for depression
101 finance2026-02-19 16:48:36
AI-Driven Innovation Accelerates Tempus AI's Expansion Across MedTech
Finviz2026-02-20 15:09:45
Magic Mushrooms, Hard Cash: Compass Pathways' Trial Win, Fast Raise
Finviz2026-02-20 16:15:09
U.S. Food and Drug Administration (FDA) Accepts Teva's New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults
Finviz2026-02-20 19:48:38
Psyence BioMed Announces Exercise of Put Option by PsyLabs and Strategic Equity Investment
Finviz2026-02-20 22:21:43
Steve Jobs Was Notoriously Demanding But Pixar's Ed Catmull Never Had A Loud Disagreement With The Apple Co-Founder: This Is His Secret
Finviz2026-02-21 18:03:46
Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors
Finviz2026-02-23 12:33:46
BrainsWay to Participate in the Citi 2026 Unplugged MedTech and Life Sciences Access Day
Finviz2026-02-23 13:03:50
Nexalin Participates in and Commends Recent Congressional Momentum Supporting Deep Brain Neurostimulation Research for Veterans and Neurological Disorders
Finviz2026-02-23 13:21:40
EXCLUSIVE: Penny Stock Nexalin Advances Pivotal Trial Aiming To Tackle Severe Insomnia
Finviz2026-02-24 12:54:08
Ardelyx and the LPGA Announce Multi-Year Partnership to Break Stigma Around Digestive Health Issues Impacting Millions
Finviz2026-02-24 13:03:09
BrainsWay to Report Fourth Quarter and Full Year 2025 Financial Results on March 11, 2026
Finviz2026-02-25 13:03:48
HIMS vs. AMWL: Which Telehealth Stock Is the Better Investment Now?
Finviz2026-02-25 18:42:41
Eton Pharmaceuticals Announces U.S. FDA Approval for DESMODA (desmopressin acetate) Oral Solution
Finviz2026-02-25 18:51:43
Talkspace to Participate in Upcoming Investor Conferences
Finviz2026-02-25 21:09:44
Motorola Solutions Posts Modest 0.10 Gain as Major Philanthropy Drives 295th Ranked Market Activity
101 finance2026-02-25 23:51:49
BioXcel Therapeutics to Host Virtual Roundtable Featuring Leading Medical Experts Addressing Latest Developments in Treatment of Acute Agitation in Alzheimer's Dementia
Finviz2026-02-19 12:03:42
BrainsWay Announces New Minority-Stake Investment in Canadian Provider, BrainStim Health Inc.
Finviz2026-02-19 12:33:04
Talkspace Announces Fourth Quarter and Full Year 2025 Results
Finviz2026-02-19 13:03:12
20/20 BioLabs Debuts Trading on Nasdaq Under Ticker Symbol "AIDX" Following 3 Consecutive Years of Sales Growth
Finviz2026-02-19 14:03:33
FDA could approve magic mushroom chemical for depression
101 finance2026-02-19 16:48:36
AI-Driven Innovation Accelerates Tempus AI's Expansion Across MedTech
Finviz2026-02-20 15:09:45
Magic Mushrooms, Hard Cash: Compass Pathways' Trial Win, Fast Raise
Finviz2026-02-20 16:15:09
U.S. Food and Drug Administration (FDA) Accepts Teva's New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults
Finviz2026-02-20 19:48:38
Psyence BioMed Announces Exercise of Put Option by PsyLabs and Strategic Equity Investment
Finviz2026-02-20 22:21:43
Steve Jobs Was Notoriously Demanding But Pixar's Ed Catmull Never Had A Loud Disagreement With The Apple Co-Founder: This Is His Secret
Finviz2026-02-21 18:03:46
Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors
Finviz2026-02-23 12:33:46
BrainsWay to Participate in the Citi 2026 Unplugged MedTech and Life Sciences Access Day
Finviz2026-02-23 13:03:50
Nexalin Participates in and Commends Recent Congressional Momentum Supporting Deep Brain Neurostimulation Research for Veterans and Neurological Disorders
Finviz2026-02-23 13:21:40
EXCLUSIVE: Penny Stock Nexalin Advances Pivotal Trial Aiming To Tackle Severe Insomnia
Finviz2026-02-24 12:54:08
Ardelyx and the LPGA Announce Multi-Year Partnership to Break Stigma Around Digestive Health Issues Impacting Millions
Finviz2026-02-24 13:03:09
BrainsWay to Report Fourth Quarter and Full Year 2025 Financial Results on March 11, 2026
Finviz2026-02-25 13:03:48
HIMS vs. AMWL: Which Telehealth Stock Is the Better Investment Now?
Finviz2026-02-25 18:42:41
Eton Pharmaceuticals Announces U.S. FDA Approval for DESMODA (desmopressin acetate) Oral Solution
Finviz2026-02-25 18:51:43
Talkspace to Participate in Upcoming Investor Conferences
Finviz2026-02-25 21:09:44
Motorola Solutions Posts Modest 0.10 Gain as Major Philanthropy Drives 295th Ranked Market Activity
101 finance2026-02-25 23:51:49
TSE:9218 stock price change
On the last trading day, TSE:9218 stock closed at 786.00 JPY, with a price change of -1.75% for the day.
Trade stock perpsTSE:9218 stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more